User:Mr. Ibrahem/Rasburicase

Rasburicase, sold under the brand names Elitek among others, is a medication used for high uric acid levels that occur as a result of tumor lysis syndrome. It is given by gradual injection into a vein.

Common side effects include nausea, fever, swelling, anxiety, headache, diarrhea, and low phosphate. Other side effects may include anaphylaxis and methemoglobinemia. It should not be used in people with G6PD deficiency. It is the urate oxidase enzyme created by recombinant DNA technology.

Rasburicase was approved for medical use in Europe in 2001 and the United States in 2002. It is on the World Health Organization's List of Essential Medicines. In the United Kingdom it costs the NHS about £350 per 7.5mg vial as of 2021. This amount in the United States costs about 5,000 USD.